Preclinical studies in murine models have shown that postbiotics may be able to increase fecal IgA levels and stabilize the longitudinal development of microbiota, thereby protecting mucosal surfaces from pathogenic infections and downregulating ongoing inflammatory processes in inflamed tissues [27]. Here, CD79A is linked to infection.